Skin health

On this page:

• Dupixent^B
• Ozanex
• Sitavig
• Tremfya^B

Dupixent^B

(new active substance)

Medical ingredient:

Dupilumab

Indication:

Dupixent is an injectable prescription medicine used to treat adult patients with moderate-to-severe atopic dermatitis, also known as atopic eczema.

For more information, see the Regulatory Decision Summary.

Ozanex

(new active substance)

Medical ingredient:

Ozenoxacin

Indication:

Ozanex is a medication which is applied on the skin to treat bacterial skin infections.

For more information, see the Summary Basis of Decision.

Sitavig

Medical ingredient:

Acyclovir

Indication:

Sitavig is a medication that is applied once to treat outbreaks of cold sores (herpes labialis) in adults.

For more information, see the Regulatory Decision Summary.

Tremfya^B

(new active substance)

Medical ingredient:

Guselkumab

Indication:

Tremfya is a prescription medicine used to treat adults with moderate to severe "plaque psoriasis", an inflammatory condition affecting the skin and nails.

For more information, see the Regulatory Decision Summary.

Health Canada approved three new generic drugs for skin health.

Health Canada released three risk communications for skin health.